Abstract:Background and aims Genomic and transcriptomic findings greatly broaden the biological knowledge regarding substance use. However, systematic convergence and comparison evidence of genome-wide findings is lacking for substance use. Here, we combined all the genome-wide findings from both substance use behavior and disorder (SUBD) and identified common and distinguishing genetic factors for different SUBDs. Methods Systemic literature search for genome-wide association (GWAS) and RNA-seq studies of alcohol/nicotine/drug use behavior (partially meets or not reported diagnostic criteria) and alcohol use behavior and disorder (AUBD), nicotine use behavior and disorder (NUBD) and drug use behavior and disorder (DUBD) was performed using PubMed and the GWAS catalog. Drug use was focused upon cannabis, opioid, cocaine and methamphetamine use. GWAS studies required case-control or case/cohort samples. RNA-seq studies were based on brain tissues. The genes which contained significant single nucleotide polymorphism (P <= 1 x 10(-6)) in GWAS and reported as significant in RNA-seq studies were extracted. Pathway enrichment was performed by using Metascape. Gene interaction networks were identified by using the Protein Interaction Network Analysis database. Results Total SUBD-related 2910 genes were extracted from 75 GWAS studies (2 773 889 participants) and 17 RNA-seq studies. By overlapping the genes and pathways of AUBD, NUBD and DUBD, four shared genes (CACNB2, GRIN2B, PLXDC2 and PKNOX2), four shared pathways [two Gene Ontology (GO) terms of 'modulation of chemical synaptic transmission', 'regulation of trans-synaptic signaling', two Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways of 'dopaminergic synapse', 'cocaine addiction'] were identified (significantly higher than random, P < 1 x 10(-5)). The top shared KEGG pathways (Benjamini-Hochberg-corrected P-value < 0.05) in the pairwise comparison of AUBD versus DUBD, NUBD versus DUBD, AUBD versus NUBD were 'Epstein-Barr virus infection', 'protein processing in endoplasmic reticulum' and 'neuroactive ligand-receptor interaction', respectively. We also identified substance-specific genetic factors: i.e. ADH1B and ALDH2 were unique for AUBD, while CHRNA3 and CHRNA4 were unique for NUBD. Conclusions This systematic review identifies the shared and unique genes and pathways for alcohol, nicotine and drug use behaviors and disorders at the genome-wide level and highlights critical biological processes for the common and distinguishing vulnerability of substance use behaviors and disorders.

Epistatic evidence for gender-dependant slow neurotransmission signalling in substance use disorders: PPP1R12B versus PPP1R1B

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

GENETIC STUDY: an Association of Prodynorphin Polymorphisms and Opioid Dependence in Females in a Chinese Population

An Association Study Revealed Substantial Effects of Dominance, Epistasis and Substance Dependence Co‐morbidity on Alcohol Dependence Symptom Count

Sex-specific differences in brain activity dynamics of youth with a family history of substance use disorder

Common and Distinguishing Genetic Factors for Substance Use Behavior and Disorder: an Integrated Analysis of Genomic and Transcriptomic Studies from Both Human and Animal Studies

Polymorphisms Of Genes In Neurotransmitter Systems Were Associated With Alcohol Use Disorders In A Tibetan Population

AZI23’UTR Is a New SLC6A3 Downregulator Associated with an Epistatic Protection Against Substance Use Disorders

Association Analysis of the Protein Phosphatase 1 Regulatory Subunit 1B (PPP1R1B) Gene with Nicotine Dependence in European‐ and African‐American Smokers

T96GENETIC STUDY FOR SUBSTANCE DEPENDENCE AND ITS GENETIC CORRELATION WITH PSYCHIATRIC DISORDERS

Identification of Novel Risk Loci with Shared Effects on Alcoholism, Heroin, and Methamphetamine Dependence

Genome-wide Association Study Identifies Common Genetic Risk Factors for Alcohol, Heroin and Methamphetamine Dependence

Divergent gene expression patterns in alcohol and opioid use disorders lead to consistent alterations in functional networks within the dorsolateral prefrontal cortex

3’UTR Is a New Downregulator Associated with an Epistatic Protection Against Substance Use Disorders

Genetic and epigenetic analysis revealing variants in the NCAM1-TTC12-ANKK1-DRD2 cluster associated significantly with nicotine dependence in Chinese Han smokers.

Converging Evidence Implicates the Dopamine D3 Receptor Gene in Vulnerability to Schizophrenia

The effects of BDNF rs6265 and FGF21 rs11665896 polymorphisms on alcohol use disorder-related impulsivity in Han Chinese adults

GABRB1 Single Nucleotide Polymorphism Associated with Altered Brain Responses (but Not Performance) During Measures of Impulsivity and Reward Sensitivity in Human Adolescents.

Neural Network Connectivity Following Opioid Dependence is Altered by a Common Genetic Variant in the µ-Opioid Receptor, OPRM1 A118G

Implication of Genes for the N -Methyl- d -Aspartate (NMDA) Receptor in Substance Addictions